PCR222 Characterizing Improvements in Physical Functioning with PROMIS-PF and In-Trial Exit Interviews: A Mixed-Methods Analysis to Understand the Meaningful Changes Experienced by TGCT Patients on Vimseltinib in the MOTION Trial
Abstract
Authors
Heather Gelhorn Katelyn N. Cutts Tsion Fikre Yipin Han Christopher Tait Nicholas Zeringo Amanda Saunders Brooke Harrow